Characteristics | N (%)/median (IQRa) |
---|---|
Gender | |
Male | 112(91.1%) |
Female | 11(8.9%) |
Age | 58(47-64) |
< 60 | 69(56.1%) |
≥60 | 54(43.1%) |
Aetiology of liver disease | |
Hepatitis B | 117(95.2%) |
Hepatitis C | 3(2.4%) |
Alcoholic cirrhosis | 3(2.4%) |
BCLC classificationa | |
A | 14(11.4%) |
B | 27(22.0%) |
C | 71(57.7%) |
D | 11(8.9%) |
PVTTa | |
No | 43(35.0%) |
Yes | 80(65.0%) |
Number of tumors | |
Single | 42(34.1%) |
Multiple | 81(65.9%) |
MELDa | 14.50(13.34-15.75) |
<15 | 76(61.8%) |
≥15 | 47(38.2%) |
Symptomatic portal hypertension | |
Refractory ascites | 51(41.5%) |
Variceal bleeding | 49(39.8%) |
Both | 23(18.7%) |
Refractory diarrhea | 5(4.1%) |
Laboratory tests | |
Platelets [109/L] | 88(65-125) |
INRa | 1.26(1.15-1.43) |
AST [U/L] a | 46.3(34.0-65.0) |
ALT [U/L] a | 37.6(25.4-52.1) |
Albumin [g/dL] | 33.2(30.2-36.8) |
Creatinine [mg/dL] | 72(62.2-86.5) |
Bilirubin [mg/dL] | 29.8(19.2-41.0) |
AFP [ng/mL] a | 16.2(4.81-463.78) |
<100 | 42(34.1%) |
≥100 | 81(65.9%) |